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ABSTRACT:		
	
Introduction:	 Modern	 practice	 of	Medicine	 includes	 the	 use	 of	 technological	 innovations	 such	 as	 in	Medical	
Imaging.	In	vivo	imaging	techniques	can	be	used	to	evaluate	biological	structures	and	functions	non-invasively	in	
almost	all	living	subjects.		
	
This	thesis	was	highlighted	 in	Nuclear	Medicine.	As	a	simple	definition,	Nuclear	Medicine	 is	a	medical	 imaging	
modality	based	on	the	measurement	of	an	internal	source	from	an	internal	tracer	using	radiolabeled	compounds	
to	study	in	vivo	physiologic	processes.	So,	Nuclear	Medicine	relies	on	the	supply	of	radionuclides.	
	
In	the	specific	context	of	Positron	Emission	Tomography	(PET)	imaging,	positron	emitters	are	used	to	label	several	
different	compounds,	allowing	the	study	of	almost	all	the	major	biological	systems.	Although	there	are	several	
radionuclides	to	be	potentially	applied	in	PET	imaging,	routine	clinical	applications	are	still	based	on	a	small	group	
constituted	 by	 18F,	 11C,	 13N	 and,	 more	 recently,	 68Ga.	 	 However,	 recent	 literature	 indicates	 that	 this	 trend	 is	
changing.	Among	others,	45Ti	is	being	proposed	as	a	potential	candidate	for	PET	imaging,	since	it	presents	some	
interesting	 properties:	 abundant	 positron	 emission,	 reduced	 positron	 energy,	 physical	 half-life	 of	 3.09	 h,	 and	
relevant	chemical	properties	(that	enable	radiolabeling	with	bifunctional	chelates),	ligands	or	even	to	radiolabel	
titanium	 dioxide	 nanoparticles.	 Given	 this,	 several	 issues	 should	 be	 solved	 before	 the	 real	 possibility	 of	
implementing	45Ti	clinical	applications.	
	
Aim:	Radionuclide	production	is	the	first	crucial	technical	step	involved	in	PET.	However,	production	of	45Ti	is	yet	
very	poorly	explored	in	literature.	This	project	was	designed	and	implemented	with	the	aim	to	study	the	viability	
of	the	production	of	45Ti	in	low	energy	cyclotrons,	expecting	the	characterization	of	the	excitation	functions	of	the	
appropriate	 nuclear	 reaction,	 yield	 determination	 and	 development	 of	 a	 critical	 analysis	 to	 select	 the	 best	
methodology.	
	
Materials	 and	 Methods:	 To	 evaluate	 nuclear	 reaction	 excitation	 functions	 one	 should	 implement	 nuclear	
activation	 studies.	 Nevertheless,	 the	 execution	 of	 nuclear	 activation	 studies	 deserves	 special	 attention	 and	 a	
careful	integration	of	all	the	available	information	already	collected.	In	this	sense,	the	first	step	of	this	activation	
experiment	was	the	adequate	planning	using	Monte	Carlo	simulation	codes	in	a	way	to	obtain	several	results	that	
were	totally	integrated	in	the	design	of	experimental	studies.		
	
Before	the	experimental	activation	study,	some	preliminary	experimental	studies	with	gamma-spectroscopy	were	
performed	with	 calibrated	 radionuclide	 sources	 as	 demonstration	 of	 the	 ability	 of	 the	 technique	 to	 illustrate	
physical	phenomena,	such	as,	radioactive	decay	and	radiation	interaction	with	matter,	and	in	a	way	to	refine	the	
analysis	of	the	main	experiment.	Then,	the	stacked	foil	technique	was	implemented	in	a	18	MeV	cyclotron	to	study	
the	45Sc(p,n)45Ti	nuclear	reaction	and	its	feasibility	to	effectively	produce	45Ti.	Activation	was	measured	using	HPGe	
gamma-spectroscopy.	 	 Theoretical	 insights	 about	 the	 potential	 applications	 of	 45Ti	 for	 PET	 imaging	were	 also	
reviewed,	analyzed,	proposed	and	discussed.	
	
Results:	According	to	TALYS	code,	and	also	due	to	other	practical	considerations,	45Sc(p,n)45Ti	nuclear	reaction	
was	selected	as	the	one	with	much	more	potential	for	industrial	implementation	in	the	way	to	obtain	significant	
quantities	of	45Ti.	SRIM	code	simulations	were	used	to	understand	the	beam	energy	degradation	along	the	stacked	
foil	designed	for	the	activation	study,	while	SSSM	sub-routine	was	used	to	study	the	implantation	of	the	beam	in	
the	successive	targets.		
	
Results	of	the	main	excitation	function	were	collected	under	this	study,	with	the	addition	of	information	regarding	
concurrent	reactions	leading	to	44mSc,	44Sc	and	44Ti.	Experimental	results	showed	that	45Sc(p,n)45Ti	nuclear	reaction	
seems	 to	 be	 feasible	 in	 low	 energy	 cyclotrons,	 with	 cross-section	 values	 presenting	 a	 peak	 for	 proton	 beam	
energies	in	the	range	between	14	and	10	MeV,	while	energies	higher	than	17	MeV	should	be	avoided	due	to	the	
increased	production	of	contaminants,	such	as	44Ti,	44Sc	and	44mSc.	Thick	target	yield	for	a	saturation	condition	was	
experimentally	determined	as	433.64	MBq.µA-1sat.	
	
Theoretical	evidence	collected	demonstrate	that	45Ti	could	provide	good	PET	image	quality,	with	some	preclinical	
applications	already	tested	in	studies	related	to	a	new	class	of	anticancer	drugs	based	on	titanium	complexes.	
Other	 possible	 applications	 already	 cited	 include	 45Ti-ligands	 for	 theranostics	 and	 personalized	 medicine.	 An	
innovative	proposal	on	the	use	of	45Ti	to	radiolabel	of	titanium	dioxide	nanoparticles	will	also	be	presented	and	
discussed.	
	
Conclusion:	 There	 is	 the	 possibility	 to	 effectively	 obtain	 significant	 quantities	 of	 45Ti	 allowing	 its	 possible	
commercial	and	industrial	production,	distribution	and	use.	Given	this,	45Ti	could	then	provide	good	PET	images	
and	 be	 used	 for	 labeling	 different	 compounds	 already	 tested	 or	 to	 be	 incorporated	 in	 the	 development	 of	
nanoparticle-based	radiopharmaceuticals.	
	
	
References	to	author	publications	that	relate	specifically	to	the	dissertation:	
	
1. P.	Costa,	M.	Naia.	“Gamma	Spectroscopy:	Code	for	Analysis	and	Simulation”,	Oral	Communication	 in	Física	2012,	
Aveiro	(2012);	
2. P.	 Costa,	 F.	 Alves,	 M.	 Duarte	 Naia,	 L.F.	 Metello.	 “New	 methods	 using	 low	 energy	 cyclotrons	 in	 radioisotope	
production	for	Nuclear	Medicine”,	Poster	 in	E3	Forum	-	Education,	Employment	&	Entrepreneurship	Conference,	
Lisboa	(2013);	
3. P.	Costa,	L.F.	Metello,	F.	Alves,	M.	Duarte	Naia.	“Application	of	Monte	Carlo	simulation	codes	to	plan	an	activation	
experiment	in	Scandium-45	targets”,	Poster	in	Annual	Congress	of	the	European	Association	of	Nuclear	Medicine,	
Goteborg	(2014);	
4. P.	Costa,	L.F.	Metello,	F.	Alves,	M.	Duarte	Naia.	PET	imaging	using	Titanium-45:	Could	it	be	useful?	Nuclear	Medicine	
and	Biology.	2014;	41(7).	DOI:	10.1016/j.nucmedbio.2014.05.129	
5. P.	Costa,	L.	Cunha,	R.R.	Johnson,	W.	Gelbart,	C.	Artner,	F.	Alves,	M.	Duarte	Naia,	L.F.	Metello.	“Using	Monte	Carlo	to	
approach	 45Ti	 direct	 production	 on	 low	 energy	 –	medical	 –	 cyclotrons”,	 Oral	 Communication	 in	 Cycleur	 2014	 –	
Cyclotron	European	Network	Workshop,	Ispra	(2014);	
6. P.	Costa,	L.F.	Metello,	L.	Cunha,	R.R.	Johnson,	W.	Gelbart,	J.	Obermair,	C.	Artner,	S.	Carmo,	F.	Alves,	M.	Duarte	Naia.	
“Experimental	results	on	excitation	functions	for	45Ti	direct	production	on	low	energy	–	medical	–	cyclotrons”,	Oral	
Communication	in	11th	Cycleur	–	Cyclotron	European	Network	Workshop,	Monastir	(2015);	
7. P.	Costa,	L.F.	Metello,	L.	Cunha,	P.	Lass,	G.	Currie,	R.R.	Johnson,	W.	Gelbart,	J.	Obermair,	C.	Artner,	F.	Alves,	M.	Duarte	
Naia.	“45Ti-Titanium:	from	cyclotron	production	to	potential	applications	evaluation”,	Oral	Communication	 in	Low	
Dose	PT,	Lisboa	(2015);	
8. P.	Costa,	 L.F.	Metello,	F.	Alves,	M.	Duarte	Naia.	 “The	use	of	 radiolabeled	nanoparticles	 for	biomedical	 imaging”,	
Poster	in	Low	Dose	PT,	Lisboa	(2015);	
9. P.	Costa,	 L.	Cunha,	L.F.	Metello.	“The	role	of	 the	Nuclear	Medicine	Technologist	 in	cyclotron	related	Research	&	
Development”,	Oral	Communication	in	Annual	Congress	of	the	European	Association	of	Nuclear	Medicine,	Hamburg	
(2015);	
10. P.	Costa,	L.F.	Metello,	L.	Cunha,	R.R.	Johnson,	L.	Mattei,	W.	Gelbart,	J.	Obermair,	B.	Dietl,	R.	Nauschnig,	C.	Artner,	P.	
Lass,	G.	Currie,	S.	Carmo,	F.	Alves,	M.	Duarte	Naia.	“Cyclotron	produced	45Ti-Titanium:	why	&	how…so	Why	Not?”,	
Poster	in	5th	Symposium	on	Medical	Radionuclides,	Brussels	(2015);	
11. P.	Costa,	L.F.	Metello,	L.	Cunha,	R.R.	Johnson,	L.	Mattei,	W.	Gelbart,	J.	Obermair,	B.	Dietl,	R.	Nauschnig,	C.	Artner,	P.	
Lass,	G.	 Currie,	 S.	 Carmo,	 F.	 Alves,	M.	Duarte	Naia.	 “Excitation	 function	 determination	 for	 45Ti	 production	 using	
45Sc(p,n)45Ti	reaction	using	low	energy	cyclotrons”,	Poster	in	Annual	Congress	of	the	European	Association	of	Nuclear	
Medicine,	Hamburg	(2015)	
12. P.	Costa,	M.	Naia,	F.	Alves,	L.F.	Metello.	“Development	of	45Ti	for	radiopharmaceutical	purposes:	results	obtained	
and	future	perspectives”,	Oral	Communication	in	12th	Cycleur	–	Cyclotron	Cyclotron	European	Network	Workshop	
–	and	2nd	Bern	Cyclotron	Symposium,	Bern	(2016);	
	
